# CardiacEPAI - Electrophysiology Studies & Ablation Platform

## Executive Summary

CardiacEPAI is an AI-powered platform designed specifically for cardiac electrophysiologists that automates EP study interpretation, arrhythmia detection (AFib, VT, SVT), ablation guidance, pacemaker/ICD optimization, and device clinic workflow. The platform addresses the growing complexity of electrophysiology procedures while improving patient outcomes and reducing procedure time.

---

## Name

**CardiacEPAI - Electrophysiology Studies & Ablation Platform**

---

## Core Concept

AI-powered platform for cardiac electrophysiologists that automates EP study interpretation, arrhythmia detection (AFib, VT, SVT), ablation guidance, pacemaker/ICD optimization, and device clinic workflow.

---

## Problem

### Market Pain Points

1. **EP Study Complexity**
   - Intracardiac EGM signals require interpretation from 20+ electrodes
   - Manual analysis time: 30-60 minutes per study
   - Signal-to-noise challenges require expertise
   - Fellowship-trained EPs required for accurate interpretation

2. **Arrhythmia Epidemic**
   - 6M+ Americans with atrial fibrillation
   - Projected 12M+ by 2030 (aging population)
   - AFib treatment costs: $26B annually in US
   - Ventricular tachycardia: high mortality, complex management

3. **Ablation Procedure Challenges**
   - Duration: 3-6 hours per procedure
   - Radiation exposure for patients and staff
   - Recurrence rates: 20-30% (gaps in lesion formation)
   - Subjective endpoint determination (is the line complete?)
   - Transmurality assessment is challenging

4. **Device Clinic Burden**
   - Pacemaker/ICD implants increasing (~300K annually)
   - Remote monitoring data volume overwhelming
   - Optimization is time-consuming (AV/VV timing)
   - Inappropriate ICD shocks: 20-30% of shocks
   - Device clinic staffing shortage

5. **Training Gap**
   - EP fellowships: 2-3 years
   - Complex arrhythmias require extensive experience
   - Training cases limited by availability

---

## Target Vertical

### Primary: Cardiac Electrophysiologists

**EP Lab Directors**
- Decision-makers for technology adoption
- Responsible for lab efficiency metrics
- Interested in research opportunities

**Electrophysiology Physicians**
- Perform 5-15 EP studies/week
- Perform 3-8 ablations/week
- Manage device clinic patients
- Tech-savvy early adopters

**Fellowship Trainees**
- Learning EP interpretation
- Need decision support
- High engagement with educational tools

### Secondary Markets

**Cardiologists with EP Training**
- General cardiologists performing basic EP studies
- Community hospitals without full EP labs

**EP Labs (Institutional Sales)**
- Hospital-based electrophysiology labs
- Academic medical centers
- Ambulatory surgery centers

**Device Clinics**
- Hospital-based device clinics
- Independent device monitoring centers
- Cardiology practice device services

---

## Why Now

### 1. Market Timing

**AFib Prevalence Explosion**
- Aging population (10,000 boomers turn 65 daily)
- AFib incidence doubles each decade after 50
- Obstructive sleep apnea comorbidity rising
- Wearables detecting asymptomatic AFib

**Ablation Technology Advancement**
- Cryoablation: faster AFib procedures
- Pulsed field ablation: safer, faster adoption
- Laser balloon: alternative energy sources
- High-density mapping catheters: more data points

**2. Technology Readiness**

**EGM Signal Processing ML = Mature**
- Time-series CNNs proven for ECG signals
- Transfer learning from ECG datasets
- Attention mechanisms for arrhythmia localization
- Real-time inference capabilities on edge devices

**Device Data Accessibility**
- Remote monitoring standard of care
- USB/optical data extraction from programmers
- EHR integration requirements improving
- HL7/FHIR standards adoption

**3. Clinical Practice Trends**

**Device Clinic Overload**
- Remote monitoring alerts: 10-50 per physician daily
- In-person device checks: 20-40 per clinic
- Prior authorization burden increasing
- Staffing shortages nationwide

**Quality Metrics Emphasis**
- Ablation success rates publicly reported
- Readmission penalties
- Device complication tracking
- Patient satisfaction scores

**4. Regulatory Environment**

**FDA AI/ML Framework Evolving**
- Predetermined Change Control Plans (PCCP)
- SaMD (Software as Medical Device) pathways clearer
- Real-world evidence acceptance growing
- Breakthrough Device Program available

**5. Physician Receptivity**

**EP Physicians = Early Adopters**
- Comfortable with complex technology
- Used to 3D mapping systems
- Data-driven decision making
- Academic orientation (evidence-based)

---

## AI Advantage

### 1. EGM Signal Processing ML

**Arrhythmia Classification**
- AFib vs. atrial tachycardia vs. sinus rhythm
- SVT mechanism differentiation (AVNRT vs. AVRT)
- VT morphology analysis
- Accessory pathway localization
- Sensitivity: >95%, Specificity: >93%

**Signal Enhancement**
- Noise reduction from catheter motion
- Far-field signal suppression
- Low-amplitude signal enhancement
- Real-time signal quality assessment

**Activation Mapping**
- Automated activation time annotation
- Conduction velocity calculation
- Reentrant circuit identification
- Focal vs. reentrant differentiation

### 2. Ablation Lesion Prediction

**Lesion Quality Assessment**
- Impedance drop pattern analysis
- Electrogram amplitude reduction monitoring
- Temperature profile assessment
- Contact force integration (when available)

**Gap Detection**
- Voltage mapping gap identification
- Conduction across ablation line detection
- Gap localization for touch-up
- Predictive model for recurrence risk

**Procedure Optimization**
- Ablation duration prediction
- Power settings recommendations
- Catheter positioning guidance
- Endpoint determination support

### 3. Pacemaker Optimization Algorithms

**AV Timing Optimization**
- Echo-derived AV intervals
- Hemodynamic optimization
- P-wave synchronized optimization
- Activity-based adaptive algorithms

**VV Timing Optimization** (CRT)
- QRS duration minimization
- ECG vector analysis
- Hemodynamic impact prediction
- Phrenic nerve capture avoidance

**Rate-Adaptive Programming**
- Sensor-driven rate response
- Activity profile learning
- Auto-adaptive parameters
- Exercise tolerance optimization

### 4. ICD Shock Reduction

**Appropriate vs. Inappropriate Detection**
- SVT discrimination enhancement
- Lead noise detection
- T-wave oversensing identification
- Atrial fibrillation with rapid ventricular response

**Antitachycardia Pacing Optimization**
- VT termination prediction
- ATP zone configuration
- Burst vs. ramp pacing selection
- Acceleration risk assessment

**Shock Minimization**
- Detection interval optimization
- VF vs. VT discrimination
- Post-shock pause reduction
- Syncope prediction

### 5. Device Clinic Workflow Automation

**Remote Monitoring Triage**
- Alert prioritization
- Normal vs. abnormal classification
- Trend analysis for early detection
- False positive reduction

**Report Generation**
- Automated device interrogation summaries
- Parameter change recommendations
- Letter templates for referring physicians
- Patient-friendly summaries

**Device Longevity Prediction**
- Battery voltage projection
- Replacement timing recommendations
- Longevity optimization strategies
- Cost prediction for budgeting

---

## Viral Mechanism

### 1. Professional Society Penetration

**Heart Rhythm Society (HRS)**
- Annual conference: 15,000+ attendees
- Abstract submissions highlighting AI outcomes
- "Innovation Theater" presentations
- Hands-on demo sessions

**Chapter-Level Events**
- Regional HRS chapter meetings
- Local EP lab director gatherings
- "Lunch and learn" sponsorship

### 2. Case Study Diffusion

**"This AI Caught What I Missed"**
- Anonymous case submission platform
- Peer-reviewed case reports
- Video demonstrations of missed diagnoses
- Quantified clinical impact

**Complication Avoidance Stories**
- Abnormal EGM patterns preventing misdiagnosis
- Inappropriate shock prevention cases
- Device malfunction early detection

### 3. EP Lab Referral Networks

**Academic Medical Centers**
- Fellowship programs adopt → trainees spread
- Research collaboration opportunities
- Multi-center study participation

**Community Hospital EP Labs**
- Referral relationships with academic centers
- Coverage arrangements drive consistency
- Group purchasing organizations

### 4. Device Clinic Efficiency Sharing

**Benchmarking Data**
- Anonymous productivity comparisons
- Device check time reductions
- Alert burden reduction metrics
- Staffing optimization data

**Patient Satisfaction**
- Faster device check turnaround
- Fewer inappropriate shocks
- Better optimization outcomes

### 5. Training Program Integration

**EP Fellowships**
- 150+ US EP fellowship programs
- 400+ fellows in training
- Educational module integration
- Simulation center partnerships

**Continuing Medical Education**
- CME-accredited AI training modules
- Case-based learning scenarios
- Self-assessment tools

---

## Revenue Model

### Per-Practice Subscription

**Starter Tier - $2,000/month**
- EP AI signal processing
- Arrhythmia detection (AFib, atrial tachy, SVT)
- Basic EGM analysis
- Remote monitoring triage
- Email support
- Up to 3 physicians

**Professional Tier - $3,000/month**
- Full Starter features
- Ablation guidance
- Pacemaker optimization
- ICD shock reduction algorithms
- Device clinic workflow automation
- Priority support
- Up to 8 physicians
- Quarterly training webinars

**Enterprise Tier - $6,000/month**
- Full Professional features
- Multi-location support
- Research API access
- Custom model training (institutional data)
- Dedicated success manager
- On-site training
- Unlimited physicians
- CME credits
- Data benchmarking reports

### Per-Procedure Add-On

**AI-Assisted Ablation - $100/procedure**
- Real-time lesion assessment
- Gap detection and localization
- Recurrence risk prediction
- Procedure optimization recommendations
- (Beyond 10 included procedures per month for Professional tier)

### Unit Economics

**Customer Acquisition Cost (CAC): $250**
- HRS conference booth: $15,000 → 150 leads → 20% conversion = $150/CAC
- EP journal advertising: $5,000 → 50 leads → 15% conversion = $333/CAC
- Referrals: $50 (customer referral bonuses)
- Weighted average: $250

**Lifetime Value (LTV): $108,000**
- Average subscription: $3,000/month
- Retention: 36 months (high switching costs)
- Expansion revenue: 20% over lifetime
- Churn: <5% annually

**Gross Margin: 85%**
- Infrastructure: 10%
- Support: 3%
- Customer success: 2%

**Payback Period: 1 month**
- CAC: $250
- First-month margin: $2,550
- Payback: <30 days

### Revenue Projections

**Year 1: $288K ARR**
- 8 practices at $3,000/month average
- 24 practices at end of year
- Focus: academic medical centers

**Year 2: $1.44M ARR**
- 40 practices at $3,000/month average
- Add: Enterprise tier conversions
- Expansion: per-procedure add-ons

**Year 3: $4.32M ARR**
- 120 practices
- 20% Enterprise tier mix
- International expansion (Canada, EU)

**Year 5: $12.6M ARR**
- 350 practices (17% of US EPs)
- B2B SaaS benchmarks: 20% of addressable market
- Device clinic SaaS expansion

---

## MVP in 8 Weeks

### Weeks 1-2: Data Collection & Partnerships

**EP Lab Partnership**
- Identify one EP lab partner (academic center)
- IRB approval for retrospective data use
- Data access agreement
- Initial EGM signal extraction

**Data Requirements**
- 500+ EP studies with confirmed diagnoses
- AFib, atrial tachycardia, SVT, VT cases
- 12-lead ECG同步 intracardiac EGMs
- Electrophysiologist annotations (ground truth)

**Technical Setup**
- AWS HIPAA-compliant infrastructure
- Secure data pipelines
- Annotation platform (Label Studio)
- Data storage architecture

### Weeks 3-5: Arrhythmia Detection ML

**Model Architecture**
- Time-series CNN for EGM signals
- Multi-lead attention mechanism
- Residual connections for deep learning
- Data augmentation (noise, scaling)

**Training Pipeline**
- 5-fold cross-validation
- Class imbalance handling
- Ensemble methods for robustness
- Confidence calibration

**Feature Engineering**
- Time-domain features (RR intervals, PR intervals)
- Frequency-domain features (spectral analysis)
- Morphological features (P-wave, QRS, T-wave)
- Spatial features (lead relationships)

**Model Performance Targets**
- AFib detection: Sensitivity >95%, Specificity >93%
- SVT detection: Sensitivity >92%, Specificity >90%
- VT detection: Sensitivity >90%, Specificity >95%

### Weeks 6-7: EP Lab Pilot

**Pilot Design**
- 2-week prospective validation
- 50 EP studies
- Real-time AI analysis + blinded EP physician
- Discordant case adjudication by third EP

**Validation Metrics**
- Sensitivity vs. EP physician
- Specificity vs. EP physician
- Interpretation time reduction
- User satisfaction (SUS score)

**Feedback Integration**
- UI/UX iteration
- False positive/negative analysis
- Edge case handling
- Performance optimization

### Week 8: Refinement & Demo Preparation

**Model Refinement**
- Pilot data fine-tuning
- Edge case improvements
- Confidence threshold optimization
- Real-time inference optimization

**HRS Conference Demo**
- Interactive demo platform
- Case study library
- Performance metric dashboards
- Partnership announcements

**Validation Metrics Summary**
- [ ] >0.90 sensitivity for arrhythmia detection (vs. EP physician)
- [ ] >0.90 specificity for arrhythmia detection
- [ ] 50%+ faster EGM interpretation
- [ ] >80% user satisfaction
- [ ] One EP lab commits post-pilot

---

## Tech Stack

### Backend

**Python/FastAPI**
- High-performance async framework
- OpenAPI/Swagger documentation
- WebSocket support for real-time analysis
- Pydantic validation

**Architecture**
- Microservices for scalability
- Event-driven architecture (Kafka)
- API Gateway for routing
- Service mesh (Istio)

### AI/ML

**PyTorch**
- Time-series CNN models
- Attention mechanisms
- Transfer learning from ECG models
- ONNX export for production

**Scikit-learn**
- Arrhythmia classification
- Feature selection
- Anomaly detection
- Model evaluation

**Additional ML Libraries**
- Librosa: signal processing
- Antropy: entropy measures
- Tslearn: time-series utilities
- Albumentations: augmentation

**MLOps**
- MLflow: experiment tracking
- Weights & Biases: monitoring
- Airflow: training pipelines
- Seldon: model serving

### Data Processing

**Signal Processing**
- SciPy: filtering, transforms
- NumPy: numerical operations
- Pandas: data manipulation
- Dask: parallel processing

**Feature Engineering**
- Featuretools: automated features
- Tsflex: time-series features
- Numba: performance optimization

### Integrations

**EP Lab Systems**
- Bard Electrophysiology Lab System
- Boston Scientific LabSystem
- Abbott EnSite
- Biosense Webster CARTO
- HL7/FHIR interfaces

**Device Programmers**
- Medtronic CareLink
- Boston Scientific Latitude
- Abbott Merlin
- Biotronik Home Monitoring

**EHR Systems**
- Epic (Care Everywhere)
- Cerner (HealtheIntent)
- Allscripts
- athenahealth

### Infrastructure

**AWS**
- US regions (us-east-1, us-west-2)
- HIPAA-compliant architecture
- Business Associate Agreement in place

**Services**
- EC2: compute
- S3: storage (encrypted)
- RDS PostgreSQL: database
- Lambda: serverless functions
- API Gateway: API management
- CloudFront: CDN
- Route 53: DNS

**Security**
- KMS: encryption
- Secrets Manager: credential management
- GuardDuty: threat detection
- CloudTrail: audit logging
- VPC: network isolation

### Frontend

**React/TypeScript**
- Component library (Material-UI)
- State management (Redux Toolkit)
- Real-time updates (WebSocket)
- Responsive design

**Data Visualization**
- D3.js: custom charts
- ECharts: EGM visualization
- Plotly: interactive plots
- WebGL: 3D mapping

---

## Monthly Revenue Potential

### Year 1: $24K MRR → $288K ARR

**Assumptions:**
- 8 practices by year-end
- $3,000/month ARPU
- Focus: academic medical centers
- Conversion from pilot: 25%

**Sources:**
- 2 HRS conference leads
- 3 EP journal leads
- 3 referrals from early adopters

### Year 2: $120K MRR → $1.44M ARR

**Assumptions:**
- 40 practices
- ARPU increase to $3,000/month
- Enterprise tier: 10% of practices
- Per-procedure add-ons: 15% of revenue

**Growth Drivers:**
- HRS conference momentum
- Case study publications
- Peer referrals
- Fellowship program graduates

### Year 3: $360K MRR → $4.32M ARR

**Assumptions:**
- 120 practices
- ARPU: $3,000/month
- Enterprise tier: 20% of practices
- Per-procedure add-ons: 20% of revenue
- International: 10 practices (Canada)

**Expansion:**
- Device clinic focus
- International expansion
- Enterprise tier upsell
- Research partnerships

### Year 5: $1.05M MRR → $12.6M ARR

**Assumptions:**
- 350 practices (17% of US EPs)
- ARPU: $3,000/month
- Enterprise tier: 25% of practices
- International: 50 practices
- Per-procedure add-ons: 25% of revenue

**Maturity:**
- Market leader position
- International expansion complete
- Adjacent product launches

---

## Risk Factors

### 1. FDA Regulatory Pathway

**Risk:** Class II medical device requirement
- 510(k) clearance needed
- Predicates exist but limited AI-based
- Clinical validation required
- Timeline: 12-24 months

**Mitigation:**
- Engage FDA early (Pre-Submission)
- Use Breakthrough Device Program
- Leverage de novo pathway if needed
- Plan regulatory budget: $500K-$1M
- Partner with regulatory consultants

### 2. EGM Data Access

**Risk:** Proprietary EP lab systems
- Vendor data formats closed
- Export restrictions
- Integration complexity
- Hospital IT barriers

**Mitigation:**
- Start with academic centers (research access)
- Build HL7/FHIR interfaces
- Vendor partnerships (Bard, Boston Scientific)
- Manual data import option
- Support multiple formats

### 3. Ablation Guidance Liability

**Risk:** Wrong location guidance = recurrence
- Patient harm potential
- Malpractice exposure
- Reputational damage
- Regulatory scrutiny

**Mitigation:**
- Clear decision support (not autonomous) positioning
- Physician-controlled recommendations
- Comprehensive disclaimers
- Malpractice insurance
- Clinical validation studies
- Post-market surveillance

### 4. Competitive Landscape

**Risk:** EP lab system built-in AI
- Boston Scientific AI features
- Abbott AI integration
- Biosense Webster AI mapping
- Switching costs if embedded

**Mitigation:**
- Vendor-agnostic positioning
- Multi-vendor support
- Best-of-breed features
- Faster innovation cycle
- Focus on areas vendors neglect (device optimization)

### 5. Small Market Size

**Risk:** 2,000 US EPs limited TAM
- Revenue ceiling
- Investor interest
- Growth constraints
- Exit valuation impact

**Mitigation:**
- International expansion (EU, Asia)
- Device clinic SaaS (broader market)
- Adjacent products (general cardiology)
- Per-procedure revenue
- High retention reduces acquisition pressure

### 6. Clinical Validation Burden

**Risk:** Evidence-based medicine requirements
- Randomized trials expected
- Publication standards
- Peer review scrutiny
- Adoption barriers without data

**Mitigation:**
- Start with retrospective validation
- Multi-center studies
- HRS abstract presentations
- Peer-reviewed publications
- Real-world evidence generation
- KOL engagement

### 7. Data Privacy & Security

**Risk:** HIPAA violations
- Patient data exposure
- Unauthorized access
- Breach notifications
- Legal liability

**Mitigation:**
- HIPAA-compliant infrastructure
- De-identified data for training
- Security audits (SOC 2)
- Business Associate Agreements
- Encryption at rest and in transit
- Penetration testing

---

## Competitive Threat

### Direct Competitors

**Boston Scientific (Rhythmia System)**
- EP lab system with some AI features
- Market leader in mapping systems
- Strength: Integrated hardware + software
- Weakness: Vendor-specific, limited AI

**Abbott (EnSite X)**
- EP lab system with AI mapping
- Strong in cardiology overall
- Strength: Hardware integration
- Weakness: Closed ecosystem

**Biosense Webster (CARTO)**
- Market leader in ablation mapping
- Some AI features in mapping
- Strength: Dominant catheter share
- Weakness: Limited EP study AI

### Indirect Competitors

**EP Lab Built-in AI**
- Incremental AI features
- No vendor-agnostic option
- Slow innovation cycles
- Bundled pricing

**General Cardiology AI**
- ECG analysis (Apple, iRhythm)
- Not focused on EP studies
- Lack EP expertise

### Competitive Differentiation

**Only AI Platform Covering:**
1. EP studies (all arrhythmias)
2. Ablation guidance (all energy types)
3. Device optimization (all vendors)
4. Device clinic workflow
5. Vendor-agnostic approach

**Key Advantages:**
- Multi-vendor support
- Faster innovation (SaaS vs. hardware)
- Best-of-breed AI focus
- Lower cost than hardware upgrades
- Research collaboration capabilities

---

## Go/No-Go Decision: GO

### Critical Success Factors

**1. Hire Electrophysiologists as Co-Founders/Advisors**
- Clinical credibility required
- Data access relationships
- Product validation
- Sales credibility

**Action Items:**
- Identify KOL EPs interested in AI
- Offer equity for clinical leadership
- Part-time EP chief medical officer
- EP advisory board

**2. Partner with One EP Lab for Data Access**
- IRB approval pathway
- Data extraction workflows
- Clinical validation environment
- Reference customer

**Action Items:**
- Target academic medical centers
- Offer research collaboration
- Co-authorship opportunities
- Free pilot access

**3. Start with AFib Detection (Most Common Arrhythmia)**
- Largest market (6M+ Americans)
- Highest clinical impact
- Easiest validation
- Ablation growth area

**Action Items:**
- MVP: AFib vs. sinus classification
- Expand to atrial tachycardia
- Add SVT detection
- VT in later iterations

**4. Build HRS Conference Relationships**
- Primary sales channel
- Thought leadership platform
- Partnership opportunities
- Brand awareness

**Action Items:**
- Sponsor HRS annual meeting
- Submit abstracts (case studies)
- Host "Innovation Theater" demos
- Engage HRS committees

**5. Plan Device Optimization Add-On Early**
- Addresses device clinic burden
- Broader physician use
- Subscription revenue expansion
- Competitive differentiation

**Action Items:**
- Research device optimization algorithms
- Identify key device partnerships
- Plan MVP+ features
- User research with device clinic staff

---

## Market Analysis

### Total Addressable Market (TAM)

**US Market: $150M annually**
- 2,000 cardiac electrophysiologists
- 500 EP labs
- $3,000/month × 12 months × 2,000 EPs = $72M
- Device clinic SaaS expansion = $30M
- Per-procedure add-ons = $48M

**International Market: $300M annually**
- 5,000 EPs internationally (EU, Asia, Canada)
- Similar pricing with regional adjustments
- Longer adoption timeline (5+ years)

**Total TAM: $450M annually**

### Serviceable Addressable Market (SAM)

**Year 1-3: US academic EP labs**
- 150 academic medical centers
- 30% adoption target = 45 practices
- $1.6M ARR target

**Year 3-5: US private practice EPs**
- 350 additional practices
- 40% adoption target = 140 practices
- $5M ARR expansion

### Serviceable Obtainable Market (SOM)

**Year 1:** 8 practices = $288K ARR
**Year 2:** 40 practices = $1.44M ARR
**Year 3:** 120 practices = $4.32M ARR
**Year 5:** 350 practices = $12.6M ARR

---

## Product Roadmap

### Phase 1: MVP (Months 1-3)

**Core Features:**
- EGM signal processing
- AFib detection
- Atrial tachycardia detection
- Basic UI
- One EP lab pilot

**Validation:**
- Sensitivity >90%
- Specificity >90%
- One paying customer

### Phase 2: EP Suite (Months 4-9)

**Additional Features:**
- SVT mechanism classification
- VT detection
- Activation mapping
- Ablation guidance (basic)
- Multi-EP lab support

**Validation:**
- FDA 510(k) submission
- 10 paying customers
- Peer-reviewed publication

### Phase 3: Device Optimization (Months 10-15)

**Additional Features:**
- Pacemaker AV optimization
- CRT VV optimization
- ICD shock reduction
- Remote monitoring triage
- Device clinic workflow

**Validation:**
- FDA clearance
- 50 paying customers
- Multi-center study results

### Phase 4: Enterprise & Research (Months 16-24)

**Additional Features:**
- Research API access
- Custom model training
- Multi-institution studies
- International expansion (Canada)
- EHR deep integration

**Validation:**
- 100 paying customers
- International regulatory approvals
- Research platform revenue

### Phase 5: Adjacent Products (Months 25+)

**Additional Products:**
- General cardiology ECG AI
- Patient monitoring platform
- Wearable integration
- Predictive analytics
- Telehealth support

**Validation:**
- 200+ customers
- International expansion complete
- Adjacent market validation

---

## Funding Requirements

### Seed Round: $2M

**Use of Funds:**
- Engineering: $1.2M (4 engineers, 12 months)
- Regulatory: $300K (FDA pathway, consultants)
- Clinical: $250K (EP advisors, studies)
- Sales/Marketing: $150K (HRS conference, materials)
- Operations: $100K (legal, insurance, office)

**Milestones:**
- MVP complete
- FDA 510(k) submitted
- 10 paying customers
- $100K+ ARR

### Series A: $8M (18-24 months post-seed)

**Use of Funds:**
- Engineering: $4M (12 engineers)
- Regulatory/Clinical: $1.5M (FDA clearance, studies)
- Sales/Marketing: $1.5M (team, conferences)
- Operations: $1M (international expansion)

**Milestones:**
- FDA clearance
- 50 paying customers
- $2M+ ARR
- International launch

---

## Key Metrics

### Product Metrics
- DAU/WAU/MAU (physician usage)
- Arrhythmia detection accuracy (sensitivity, specificity)
- Interpretation time reduction
- Ablation procedure time reduction
- Device optimization success rate

### Business Metrics
- MRR/ARR growth
- CAC vs. LTV
- Churn rate (target: <5% annually)
- ARPU expansion
- Per-procedure add-on attach rate

### Clinical Metrics
- Patient outcomes (recurrence rates)
- Complication rates
- Procedure success rates
- Device inappropriate shock reduction
- Patient satisfaction scores

---

## Exit Strategy

### Potential Acquirers

**EP Equipment Manufacturers:**
- Boston Scientific
- Abbott
- Biosense Webster (Johnson & Johnson)
- Medtronic

**Reasoning:**
- Strategic AI talent
- Accelerated product roadmap
- Competitive differentiation
- Customer base expansion

**Estimated Valuation:**
- 5-8x ARR at exit
- $50M-$100M range at $12M ARR

### IPO Considerations

**Requirements:**
- $50M+ ARR
- 30%+ growth rate
- Profitable or path to profitability
- Market leader position

**Timeline:**
- Series B/C required
- 7-10 year horizon

---

## Appendix

### Industry References

**Professional Societies:**
- Heart Rhythm Society (HRS)
- American College of Cardiology (ACC)
- European Heart Rhythm Association (EHRA)

**Key Publications:**
- HeartRhythm (HRS journal)
- Journal of Arrhythmia
- Circulation: Arrhythmia and Electrophysiology
- JACC: Clinical Electrophysiology

**Conferences:**
- Heart Rhythm Society Annual Scientific Sessions
- CARDIOSTIM (Europe)
- APHRS (Asia Pacific)

### Clinical References

**AFib Guidelines:**
- 2023 AHA/ACC/HRS Guideline for AFib Management
- 2022 ESC Guidelines for AFib Management

**Ablation References:**
- Catheter Ablation for AFib (CAAAT trials)
- Pulmonary Vein Isolation studies

**Device Guidelines:**
- 2021 HRS Expert Consensus on CIED Programming
- 2022 ESC Guidelines on Cardiac Pacing

### Technical References

**EGM Signal Processing:**
- Intracardiac electrogram analysis techniques
- Time-series deep learning for cardiac signals
- Activation mapping algorithms

**ML in Cardiology:**
- Deep learning for ECG analysis
- AI in cardiac electrophysiology review papers

---

*Venture Spec Version: 1.0*
*Created: March 2, 2026*
*Status: GO - Proceed with development*
